药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tasosartan
Blinatumomab
The risk or severity of adverse effects can be increased when Blinatumomab is combined with Palbociclib.
Tasosartan
Vedolizumab
The risk or severity of adverse effects can be increased when Vedolizumab is combined with Palbociclib.
Tasosartan
Obinutuzumab
The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Palbociclib.
Tasosartan
Dimethyl fumarate
The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Palbociclib.
Tasosartan
Belimumab
The risk or severity of adverse effects can be increased when Belimumab is combined with Palbociclib.
Tasosartan
Eribulin
The risk or severity of adverse effects can be increased when Eribulin is combined with Palbociclib.
Tasosartan
Wortmannin
The risk or severity of adverse effects can be increased when Wortmannin is combined with Palbociclib.
Tasosartan
Belatacept
The risk or severity of adverse effects can be increased when Belatacept is combined with Palbociclib.
Tasosartan
Abetimus
The risk or severity of adverse effects can be increased when Abetimus is combined with Palbociclib.
Tasosartan
Mepolizumab
The risk or severity of adverse effects can be increased when Mepolizumab is combined with Palbociclib.
Tasosartan
Human interferon omega-1
The risk or severity of adverse effects can be increased when Human interferon omega-1 is combined with Palbociclib.
Tasosartan
Briakinumab
The risk or severity of adverse effects can be increased when Briakinumab is combined with Palbociclib.
Tasosartan
Glatiramer
The risk or severity of adverse effects can be increased when Glatiramer is combined with Palbociclib.
Tasosartan
Interferon alfa
The risk or severity of adverse effects can be increased when Interferon alfa is combined with Palbociclib.
Tasosartan
Pirfenidone
The risk or severity of adverse effects can be increased when Pirfenidone is combined with Palbociclib.
Tasosartan
Brequinar
The risk or severity of adverse effects can be increased when Brequinar is combined with Palbociclib.
Tasosartan
2-Methoxyethanol
The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Palbociclib.
Tasosartan
Vorinostat
The risk or severity of adverse effects can be increased when Vorinostat is combined with Palbociclib.
Tasosartan
Castanospermine
The risk or severity of adverse effects can be increased when Castanospermine is combined with Palbociclib.
Tasosartan
Stepronin
The risk or severity of adverse effects can be increased when Stepronin is combined with Palbociclib.